Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,255,358,984
+$127,279,678 QoQ
Shares Held
4,988,710
-3.8% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#38
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. ABBV ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,255,358,984 | 4,988,710 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,128,079,306 | 5,186,810 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,106,076,676 | 4,840,810 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,178,957,687 | 5,091,810 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $993,959,832 | 5,354,810 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,044,249,775 | 4,984,010 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $886,689,237 | 4,989,810 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,034,974,906 | 5,240,910 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $899,195,315 | 5,242,510 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $962,819,151 | 5,287,310 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $855,311,973 | 5,519,210 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $845,887,178 | 5,674,810 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $858,420,069 | 6,371,410 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,118,524,001 | 7,018,410 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,161,331,076 | 7,186,010 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,027,830,508 | 7,658,375 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,175,146,903 | 7,672,675 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,241,304,639 | 7,657,175 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $909,464,875 | 6,716,875 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $753,339,809 | 6,983,775 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $811,072,768 | 7,200,575 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $734,769,538 | 6,789,591 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $714,068,065 | 6,664,191 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $602,171,702 | 6,874,891 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $685,815,870 | 6,985,291 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $437,281,914 | 5,739,361 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||